More infos, please [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2013-12-12 16:27 (4576 d 18:52 ago) – Posting: # 12050
Views: 22,464

Hi Kumar,

❝ I got one protocol for comparative BA study with two references (one is prodrug and other is metabolite) and one test.


Which API is used in the test product?

❝ Here people suggesting 3 comparisons T Vs R1, T Vs R2 and R1 vs R2. Is multiplicity adjustment required for this kind of studies?


BE is defined as a comparative BA with the same chemical entity (including different salts, esters). Depending one the API in the test, IMHO only T vs. R1 or T vs. R2 makes sense. Results of other comparisons are only “nice to know”.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
116 visitors (1 registered, 115 guests [including 12 identified bots]).
Forum time: 12:20 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5